GSK’s Simon Jose to be next ABPI president

January 29, 2010
Sales and Marketing ABPI, Simon Jose, appointment, sales and marketing

UK pharma industry association the ABPI has named GSK’s UK general manager Simon Jose its next president. He will take …

Jimenez

Jimenez to take over as Novartis chief

January 28, 2010
Sales and Marketing Jimenez, Novartis, Vasella

Novartis’ long-standing chief executive and chairman, Daniel Vasella is to step down from his dual position to focus upon his …

EU flag

Digital Pharma – What next for European pharma and social media?

January 28, 2010
Medical Communications Europe, digital pharma, patient information, social media

Ever since the FDA announced its social media and internet hearing last September the big question over here has been …

ScopeMedical appoints Jennifer Duffy and Andrew Wightman

January 28, 2010
Medical Communications ScopeMedical, appointment, medical communications

ScopeMedical has appointed new medical writer Jennifer Duffy (pictured left) and events manager Andrew Wightman. Jennifer has an MSc in …

Pfizer abandons 100 projects in R&D streamlining

January 28, 2010
Research and Development Pfizer

Pfizer has released details of its new consolidated pipeline following its merger with Wyeth, announcing new priority research areas, and …

Novo Nordisk HQ

Pancreatitis concerns take shine off Victoza approval

January 28, 2010
Sales and Marketing GLP-1, Novo Nordisk, Victoza

The FDA has approved Novo Nordisk’s Victoza a new once-daily injection for patients with type II diabetes. The drug will …

Cell Medica bolsters senior management

January 28, 2010
Research and Development Cell Medica, appointment, research and development

London-based cellular therapeutics company Cell Medica has made four key appointments. Dr Rainer Knaus joins the company as senior vice …

Orencia

Orencia wins expanded European licence

January 27, 2010
Sales and Marketing BMS, Orencia, rheumatoid arthritis

BMS’s Orencia has been approved in Europe to treat children aged six and over who suffer from a form of …

BBC highlights AZ’s Seroquel woes

January 27, 2010
Sales and Marketing AstraZeneca, Seroquel, industry reputation

AstraZeneca’s ongoing US legal battle over its antipsychotic drug Seroquel was highlighted this week in a BBC radio programme. AstraZeneca …

UK’s research ‘Super Cluster’ unveiled

January 27, 2010
Research and Development, Sales and Marketing ABPI, clinical research, innovation, patent box

GlaxoSmithKline chief executive Andrew Witty has hailed a new UK government ‘blueprint’ to help improve the country’s competitiveness in the …

Romaco and Ankur target oral film strip market

January 27, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Ankur, Romaco, drug delivery, film strips

Packaging and processing technology specialist Romaco has kitted out Indian drugmaker Ankur Drugs and Pharma with a production line for …

BioCeramic Therapeutics appoints Ian Brown

January 27, 2010
Research and Development BioCeramic Therapeutics, appointment, research and development

BioCeramic Therapeutics has appointed Ian Brown chief executive, taking over from Daniel Green who will remain on the board as …

In brief: European Medicines Agency news

January 26, 2010
Research and Development, Sales and Marketing Arepanrix, Arzerra, EMEA, GSK, Tysabri

GlaxoSmithKline’s influenza vaccine Arepanrix has been granted conditional marketing authorisation in Europe under an emergency fast-track procedure.It is the fourth …

Quintiles re-positions itself for changing biopharma industry

January 26, 2010
Research and Development, Sales and Marketing CRO, Quintiles

Leading services company Quintiles has unveiled a new corporate identity to help showcase the diversity of its business.The company, best …

Blog footer

Digital Pharma – Online patient recruitment drive for GSK’s anxiety drug

January 26, 2010
Research and Development GlaxoSmithKline, PTSD, digital research, orvepitant, patient recruitment

GlaxoSmithKline is readying to move its post-traumatics stress disorder candidate orvepitant into phase II trials, a move being supported by …

New ways of measuring sales performance needed

January 26, 2010
Business Services, Sales and Marketing sales force effectiveness, training

Research funded by the Chartered Institue of Management Accountants (CIMA) has helped Cranfield School of Management unveil a new framework …

Huge drug discovery database launched

January 26, 2010
Research and Development ChEMBLdb, Wellcome, genome, genomics

A huge online database of information on the properties and activities of drugs and drug-like small molecules and their targets …

Merck appoints UK leadership team

January 26, 2010
MSD, Merck & Co, appointment

Merck & Co’s UK business has unveiled its new leadership team, following last year’s merger with Schering-Plough. Merck Sharp & …

National clinical directors appointed

January 26, 2010
NHS, UK, appointment, dementia, elderly, liver disease

A trio of national clinical directors, whose areas of influence cover dementia, older people and liver disease, have been appointed …

Roche invests in production of new Herceptin formulation

January 25, 2010
Manufacturing and Production, Research and Development Herceptin, Roche

Roche will spend 190 million Swiss francs ($183m) to put production capacity in place for a new self-administered formulation of …

The Gateway to Local Adoption Series

Latest content